Chemo-selective Aziridination and Oxyamination of Alkenes with Nano-cobalt catalyst

09 June 2022, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Aziridine synthesis from readily available alkene has been a long-standing point of interest for organic chemists, owing to the widely existence in bioactive compounds and plentiful synthetic derivatizations of aziridines. Compared with using iminoiodinane or azide as the nitrogen source, the seeking for catalytic systems employing novel nitrogen transfer reagent under external oxidant-free conditions are the cutting-edge techniques in this field. Herein, a pioneering nano-cobalt catalyzed chemo-selective aziridination/oxyamination reaction from alkene and hydroxylamine is developed, this system proceeds without external oxidant and exhibits mild, efficient, atom-economic and recyclable characters. Late-stage aziridinations of drug-derived alkenes and diversified synthetic transformation of the aziridine product further expands the utility of this method. Moreover, this novel methodology represents a rare example of alkene difunctionalization under nano-catalyst, which bridges the gap between homo- and heterogeneous catalysis. Moreover, the full characterizations of the nano-cobalt catalyst and mechanistic studies including deuterium-labeled experiment and Hammet analysis were conducted, while a reasonable mechanism was also suggested accordingly.

Keywords

alkene
aziridination
oxyamination
heterogeneous cobalt
hydroxylamine

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Supporting Information of Chemo-selective Aziridination and Oxyamination of Alkenes with Nano-cobalt catalyst
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.